Lab Notes: Chimeron Bio names new CEO; Amicus Therapeutics gets positive opinion for rare disease therapy

A Philadelphia biotechnology company has named a new CEO, while a Montgomery County firm gave an update on its lead personalized therapeutic cancer vaccine.